IL-32-dependent effects of IL-1beta on endothelial cell functions
about
Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 productionIL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino SinusitisInterleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.IL-32 promotes angiogenesis.Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.Association between IL-32 genotypes and outcome in infection-associated acute lung injury.Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polypsMaintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cellsDiacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response.Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.Role of interleukin-32 in chronic rhinosinusitisNovel insights into the biology of interleukin-32.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity.A review on interleukins: The key manipulators in rheumatoid arthritis.Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis.Expression levels of novel cytokine IL-32 in periodontitis and its role in the suppression of IL-8 production by human gingival fibroblasts stimulated with Porphyromonas gingivalisInterleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.c-Jun N-terminal kinase and Akt signalling pathways regulating tumour necrosis factor-α-induced interleukin-32 expression in human lung fibroblasts: implications in airway inflammation.Ginsenoside Rb1 ameliorates lipopolysaccharide-induced albumin leakage from rat mesenteric venules by intervening in both trans- and paracellular pathway.The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.Toll-like receptor 4-mediated expression of interleukin-32 via the c-Jun N-terminal kinase/protein kinase B/cyclic adenosine monophosphate response element binding protein pathway in chronic rhinosinusitis with nasal polyps.Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.Interleukin-32: its role in asthma and potential as a therapeutic agent.
P2860
Q24317887-4DCFA2FC-2B0D-4D62-8E0B-FBE7B50D5AEEQ26753017-5FC0D92C-45C9-4915-A5FE-9A76514E7C57Q30411120-EDCF0BF4-0E38-4605-8D51-E1DA5E5EA4A5Q33555523-226E27C1-6536-4EFE-B729-33280105A0C5Q33706104-D0677800-CDF9-4CD1-99C6-4EFE6D7A75A3Q34396945-6AD4BF0A-64D2-4F62-BE86-7BBA00F5FC53Q34438283-D4DD7914-6447-438E-A55D-84B0D5E083C9Q34720467-D508505E-BABA-4931-98A5-7D8988FDEADAQ35134651-77018024-0F3D-4404-A7C3-1D8162E25DDCQ35558297-67FBD357-95AE-40AE-B3BA-AD3B2FCA6C2EQ35605921-00ED7498-736E-43A7-9871-78B66C890BFDQ35641151-38BFCE52-7F3D-4BE9-A9A1-C47D74EA0AA0Q36144197-481B3F5B-8136-4203-AB59-E0DAB081A4B0Q36316432-D5627335-ABC6-4F24-BDEB-753ECE80B74DQ36318831-0540C886-0D8B-447A-9CD1-420C9BFDD1C7Q36501927-C7109D5B-7744-4E56-AF32-7C212C0DA046Q37581596-5A07F78C-876E-494C-B66A-71DFB7D15508Q37612713-B98ABEE9-7C2D-4CDA-8D61-DFB9695E4165Q37687168-700D9230-0363-4AD6-96F1-5B403FCEDB2BQ38053080-66A37265-C558-440D-8E22-847B3DAF80BCQ38067583-6E090D4E-DEEC-4EB4-B8AE-82DE934D5D93Q38086768-63D876E7-5F40-4BAA-B86A-8077A0DEAA64Q38334454-032A06AE-E039-4558-B3A2-0F617E2FE047Q38443719-1E170E40-1EFD-4AD3-BDC9-40BE3BACF721Q38469030-BA66AD0B-CC1C-4E9B-A4A2-D7DB9EAC0056Q38502773-EDC226F7-473C-44F1-BCF8-8572F56AD750Q39029629-111DEFAD-1D57-4800-8ACA-7C398C3729EAQ39297849-C59AB589-DAB6-47DE-85F1-1CEBCF6D26F4Q39580319-563D475F-4815-45F9-8437-D733C42C57CBQ40980359-BBE4DEFD-FB03-4183-97B8-B2A3CCDAFD58Q41856799-F47F6036-5470-4CC0-9486-62C5FD43AD7EQ42236150-5D206030-89D1-4689-A898-4282F970A579Q42464535-B24817AB-1567-4C0A-B839-B3CB61BD9A15Q43622238-1B4A8D4D-3F9D-4083-BFF5-756C3845E8D2Q45046014-34A43C1F-DA2B-4763-A3D8-9C79B83BDE07Q48114983-2C9CD8F2-A683-4DC2-BF29-0343E5AC590FQ53100844-82CD6F2D-8F57-4542-AC08-D097156B3D25Q53312855-CA2E511A-4E52-4D50-A5BF-283A8E0FDF5AQ54380232-240FBA1E-7B67-4FAD-8EE0-9BE40D71A96CQ55479672-F2C944C0-0210-418D-A1BC-2689DF845EDE
P2860
IL-32-dependent effects of IL-1beta on endothelial cell functions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-32-dependent effects of IL-1beta on endothelial cell functions
@en
IL-32-dependent effects of IL-1beta on endothelial cell functions.
@nl
type
label
IL-32-dependent effects of IL-1beta on endothelial cell functions
@en
IL-32-dependent effects of IL-1beta on endothelial cell functions.
@nl
prefLabel
IL-32-dependent effects of IL-1beta on endothelial cell functions
@en
IL-32-dependent effects of IL-1beta on endothelial cell functions.
@nl
P2093
P2860
P356
P1476
IL-32-dependent effects of IL-1beta on endothelial cell functions
@en
P2093
Charles A Dinarello
Claudia A Nold-Petry
Jarod A Zepp
Norbert F Voelkel
Soo-Hyun Kim
P2860
P304
P356
10.1073/PNAS.0813334106
P407
P577
2009-02-19T00:00:00Z